Biovitrum and Swedish Orphan International have combined forming Swedish Orphan Biovitrum.
The mission of the new company is to develop and make available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

A new website is not available yet and for the time being we kindly refer to our former home pages. Go to Biovitrum’s website here.